For all the skepticism he shares with his endocrinologist brother, Karl, he bought BPC-157 from a compounding pharmacy in an attempt to alleviate his own tendinitis
A Phase 2 randomized controlled trial (NCT07437547) for hamstring injuries is now recruitingthis will be the first rigorous test of BPC-157 in humans
Its mixed with saline solution (0.9% sodium chloride) or dextrose solution (5% dextrose) before being given
S.de OliveiraR
This goal requires deliberate strategy when using metabolic peptides that suppress appetite and reduce caloric intake
Nausea (most common, especially during first 1 to 2 weeks of a new dose) Diarrhea or, just as often, constipation Vomiting (less common but more likely at 9 to 12 mg) Reduced appetite, food noise quieting down (this is the goal, not a side effect) Skin sensitivity (dysesthesia): tingling, prickly feeling, or sunburn-like skin